Neutrophil elastase/alpha 1-proteinase inhibitor complex levels decrease in plasma of cystic fibrosis patients during long-term oral beta-carotene supplementation.
Winklhofer-Roob, B M
Neutrophil elastase/alpha 1-proteinase inhibitor complex levels decrease in plasma of cystic fibrosis patients during long-term oral beta-carotene supplementation. [electronic resource] - Pediatric research Jul 1996 - 130-4 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
0031-3998
10.1203/00006450-199607000-00022 doi
Administration, Oral
Adolescent
Adult
Antioxidants--therapeutic use
Child
Child, Preschool
Cystic Fibrosis--blood
Drug Administration Schedule
Female
Humans
Leukocyte Elastase--antagonists & inhibitors
Lipid Peroxidation--drug effects
Lipid Peroxides--blood
Male
Neutrophils--enzymology
Pancreatic Elastase--antagonists & inhibitors
Serine Proteinase Inhibitors--blood
Vitamin E--blood
alpha 1-Antitrypsin--metabolism
beta Carotene--therapeutic use
Neutrophil elastase/alpha 1-proteinase inhibitor complex levels decrease in plasma of cystic fibrosis patients during long-term oral beta-carotene supplementation. [electronic resource] - Pediatric research Jul 1996 - 130-4 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
0031-3998
10.1203/00006450-199607000-00022 doi
Administration, Oral
Adolescent
Adult
Antioxidants--therapeutic use
Child
Child, Preschool
Cystic Fibrosis--blood
Drug Administration Schedule
Female
Humans
Leukocyte Elastase--antagonists & inhibitors
Lipid Peroxidation--drug effects
Lipid Peroxides--blood
Male
Neutrophils--enzymology
Pancreatic Elastase--antagonists & inhibitors
Serine Proteinase Inhibitors--blood
Vitamin E--blood
alpha 1-Antitrypsin--metabolism
beta Carotene--therapeutic use